Yale-led studies open doors for treatment of lymphoma and neuroblastoma cancers

Two new Yale-led studies elucidate protein structure and function of ALK, a protein receptor, which could contribute to new treatments for pediatric neuroblastoma and lymphoma.

Read more: https://yaledailynews.com/blog/2021/12/03/yale-led-studies-open-doors-for-treatment-of-lymphoma-and-neuroblastoma-cancers/